Search for: "Boehringer-Ingelheim"
Results 101 - 120
of 443
Sorted by Relevance
|
Sort by Date
29 Jun 2007, 5:45 am
Rather belatedly passing on an interesting case I picked up on my Lawtel update a few days ago about getting an injunction in comparative advertising cases (Boehringer Ingelheim Ltd v Vetplus Ltd [2007] EWCA Civ 584 CA (Civ Div) (Pill LJ, Longmore LJ, Jacob LJ) 20/6/2007). [read post]
21 Mar 2012, 7:46 am
BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC., ET AL., App. [read post]
8 Apr 2019, 9:59 pm
And the report notes that Boehringer Ingelheim’s... [read post]
21 Oct 2021, 9:33 pm
That drug is Cyltezo (adalimumab-adbm), produced by Boehringer Ingelheim, which obtained biosimilar approval on August 25, 2017. [read post]
21 May 2014, 1:28 pm
More Than 2000 Pradaxa Lawsuits Have Been Filed Against Boehringer, And A Company Official Has Admitted That More Than 1400 Patients Bled To Death (Posted by Tom Lamb at DrugInjuryWatch.com)Earlier this month the drug company Boehringer Ingelheim said a new analysis of a company-funded study of 18,000-patients, known as RE-LY -- which the company used to win FDA approval of its controversial blood thinner Pradaxa -- turned up 22 "new" serious bleeding events… [read post]
20 Jun 2007, 5:14 am
The balance of interests between trade mark protection and freedom of speech was the focus of attention in Boehringer Ingelheim Limited and others v VetPlus Limited [2007] EWCA Civ 584, a decision from the Court of Appeal for England and Wales this morning (Lords Justices Pill, Longmore and Jacob - the last-named giving judgment) on appeal from the decision of Mr Justice Pumfrey at [2007] EWHC 972 (Ch) not to grant interim injunctive relief in an application made by… [read post]
5 Sep 2012, 3:42 pm
Pradaxa, the blood-thinning drug made by Boehringer Ingelheim, once had so much promise. [read post]
8 Feb 2009, 5:41 pm
By Sherri Oslick --About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.Boehringer Ingelheim Vetmedica Inc. v. [read post]
3 Aug 2012, 4:45 am
A man from neighboring Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
15 Oct 2012, 9:43 am
Food and Drug Administration (FDA) has not positively identified the risk and is working with the drug’s manufacturer, Boehringer Ingelheim, to conduct a further review. [read post]
25 Feb 2015, 3:17 am
When the German pharmaceutical company Boehringer Ingelheim settled with generic manufacturer Barr, the FTC opened an investigation looking at the settlement document and also subpoenaed further documents relating to the settlement. [read post]
1 Aug 2008, 9:55 am
Court of Appeal (Civil Divison) Attorney General of Zambia v Meer Care & Desai (a firm) & Ors [2008] EWCA Civ 875 (31 July 2008) Boehringer Ingelheim KG & Anor v Swingward Ltd [2008] EWCA Civ 881 (31 July 2008) Perry & Anor v Harris (A Minor) [2008] EWCA Civ 907 (31 July 2008) Greenweb Ltd v London Borough of Wandsworth [2008] EWCA Civ 910 (31 July 2008) Platform Funding Ltd v Bank of Scotland Plc (Formerly Halifax Plc) [2008] EWCA Civ 930 (31 July… [read post]
19 Jul 2012, 1:12 pm
In 2011, Boehringer Ingelheim the makers of Pradaxa received reports of two hundred and sixty people suffering from a fatal bleed while taking the medication. [read post]
22 Nov 2010, 11:14 am
Employment National origin discrimination Where an employee falsified his call records, summary judgment was properly granted to the employer on the claim that he was terminated because of his national origin. [read post]
15 Nov 2012, 8:34 pm
The announcement by the FDA concerned the controversial blood-clot preventer made by Boehringer Ingelheim and said that Pradaxa’s risk of bleeding is in line with the more commonly prescribed drug, warfarin. [read post]
6 Jul 2011, 4:07 pm
Boehringer Ingelheim (Canada) Ltd. [read post]
6 Feb 2014, 6:41 am
According to newly unsealed legal documents, Boehringer Ingelheim, the manufacturer of the blood-thinning drug Pradaxa were anxious that an internal research paper would damage drug sales and they suggested it should be suppressed. [read post]
22 Oct 2013, 11:59 am
Bydureon (January 27, 2012) (Amylin / Eli Lilly)Liraglutide Victoza (January 25, 2010) (Novo Nordisk)Sitagliptin Januvia (October 16, 2006) (Merck) Janumet (March 30, 2007) (Merck) Janumet XR (February 2, 2012) (Merck) Juvisync (October 7, 2011) (Merck)Saxagliptin Onglyza (July 31, 2009) (Bristol Myers Squibb) Kombiglyze XR (November 5, 2010) (Bristol Myers Squibb)Alogliptin Nesina (January 25, 2013) (Takeda) Kazano (January 25, 2013)… [read post]
8 Jun 2014, 2:52 pm
Boehringer Ingelheim does not admit guilt nor accept that Pradaxa is unsafe. [read post]
25 Nov 2013, 1:44 pm
"Old" Warfarin Treatment (Posted by Tom Lamb at DrugInjuryWatch.com) A report published online in November 2013 by the medical journal JAMA: Internal Medicine, "A comparison of results of the US Food and Drug Administration's Mini-Sentinel Program with randomized clinical trials: The case of gastrointestinal tract bleeding with dabigatran", raises more drug-safety issues for the still relatively new blood thinner Pradaxa, from Boehringer Ingelheim Pharmaceuticals. [read post]
